$90.00
3.003.45%
Last update: Nov 10, 4:02 PM
Abivax SA
ABVXNASDAQ
Abivax fell 18.0% from $106.12 to $87.00, behind the S&P 500's +10.0%. Its worst day was Jun 2 (−44.1%), and its low came Jun 2 at $72.50.
Nov 10, 2025 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Abivax closed at its highest level of the year, 36.9% above where the year started.
+5.0% · S&P 500 +0.4%
EPS of $-5.45 missed the $-4.91 estimate on $5.2M revenue (est. $5.5M).
Story events cover the past 12 months · Times ET
−4.5% · S&P 500 −0.3%
Abivax closed at its lowest level of the year, 31.7% below where the year started.
−44.1%, the year's worst day, on 16M shares, the year's heaviest volume · S&P 500 +0.1%
Abivax shares rose 38.6%, while the S&P 500 rose 0.8%.
+38.6%, the year's best day · S&P 500 +0.8%
EPS of $-2.43 missed the $-1.08 estimate on $3.0M revenue (est. $1.9M).
−5.0% · S&P 500 0.0%
Where it ended: a close of $87.00 on Nov 9, 2026.
Nothing in the past 12 months.
All ABVX dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for ABVX and SPY from Benzinga historical bars. Not investment advice.
